Insmed Inc. buy Guggenheim
Start price
07.02.25
/
50%
€78.00
Target price
07.02.26
€97.77
Performance (%)
58.97%
End price
08.02.26
€124.00
Summary
This prediction ended on 08.02.26 with a price of €124.00. With a performance of 58.97% the BUY prediction by Guggenheim was a big success. Guggenheim has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.226% | -3.226% | 72.662% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
Comments by Guggenheim for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $95.00 to $101.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten